US 11268077
Materials and methods for treatment of hemoglobinopathies
granted A61KA61K31/395A61K35/28
Quick answer
US patent 11268077 (Materials and methods for treatment of hemoglobinopathies) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/395, A61K35/28, A61K38/193, A61P